I Rjasanowski

917 total citations
46 papers, 615 citations indexed

About

I Rjasanowski is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, I Rjasanowski has authored 46 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 33 papers in Surgery and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in I Rjasanowski's work include Diabetes and associated disorders (38 papers), Pancreatic function and diabetes (33 papers) and Diabetes Management and Research (26 papers). I Rjasanowski is often cited by papers focused on Diabetes and associated disorders (38 papers), Pancreatic function and diabetes (33 papers) and Diabetes Management and Research (26 papers). I Rjasanowski collaborates with scholars based in Germany, Australia and United Kingdom. I Rjasanowski's co-authors include Michael Schlosser, M. Strebelow, M. Ziegler, W. Kerner, Pamela J. Kaisaki, Stephan Menzel, Ralf Waßmuth, B Ziegler, P Heinke and H. Keilacker and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Annals of the New York Academy of Sciences.

In The Last Decade

I Rjasanowski

38 papers receiving 585 citations

Peers

I Rjasanowski
Antti‐Pekka Laine Finland
Birgitta Ehrnström Norway
Stina Axelsson Sweden
Matthias G. von Herrath United States
J. M. McNally United Kingdom
Heike E. Naserke Germany
DA Heaton United Kingdom
I Deschamps France
S Gough United Kingdom
Maki Shintani Japan
Antti‐Pekka Laine Finland
I Rjasanowski
Citations per year, relative to I Rjasanowski I Rjasanowski (= 1×) peers Antti‐Pekka Laine

Countries citing papers authored by I Rjasanowski

Since Specialization
Citations

This map shows the geographic impact of I Rjasanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Rjasanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Rjasanowski more than expected).

Fields of papers citing papers by I Rjasanowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Rjasanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Rjasanowski. The network helps show where I Rjasanowski may publish in the future.

Co-authorship network of co-authors of I Rjasanowski

This figure shows the co-authorship network connecting the top 25 collaborators of I Rjasanowski. A scholar is included among the top collaborators of I Rjasanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Rjasanowski. I Rjasanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stelter, Felix, et al.. (2009). Complement Component 3 (C 3) and Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 92(6). 287–296. 3 indexed citations
2.
Köhler, Erika, et al.. (2009). Autologous Mixed Lymphocyte Reaction in Newly Diagnosed Type-1 Diabetes*. Experimental and Clinical Endocrinology & Diabetes. 95(1). 148–156. 1 indexed citations
3.
Keilacker, H., et al.. (2009). Autoantibodies against Insulin (IAA), C-peptide (CAA), and Glucagon (GAA) in New-Onset Type 1 Diabetic Patients*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 123–128. 2 indexed citations
4.
Köhler, Erika, et al.. (2009). Phagocytic Activity of Blood Cells in Diabetic Risk Probands and Newly Diagnosed Type 1 Diabetics. Experimental and Clinical Endocrinology & Diabetes. 91(3). 259–264.
5.
Rjasanowski, I, et al.. (2009). The Higher Frequency of Type I (insulin-dependent) Diabetes in Fathers than in Mothers of Type I-Diabetic Children*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 91–96. 3 indexed citations
6.
Köhler, Erika, et al.. (2009). Effect of Lymphocytes and Serum from Probands before and after Manifestation of Type 1 (Insulin-Dependent) Diabetes on Rat Islets In Vitro. Experimental and Clinical Endocrinology & Diabetes. 92(5). 182–188.
7.
Schlosser, Michael, Kerstin Koczwara, M. Strebelow, et al.. (2005). In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia. 48(9). 1830–1832. 43 indexed citations
8.
Schlosser, Michael, J. Paul Banga, Anne‐Marie Madec, et al.. (2005). Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia. 48(5). 922–930. 50 indexed citations
9.
Schlosser, Michael, M. Strebelow, I Rjasanowski, et al.. (2004). Prevalence of Diabetes‐Associated Autoantibodies in Schoolchildren: The Karlsburg Type 1 Diabetes Risk Study. Annals of the New York Academy of Sciences. 1037(1). 114–117. 22 indexed citations
10.
Schlosser, Michael, M. Strebelow, Ralf Waßmuth, et al.. (2002). The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of β-Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive Individuals. The Journal of Clinical Endocrinology & Metabolism. 87(5). 2254–2261. 35 indexed citations
11.
Strebelow, M., Michael Schlosser, B Ziegler, I Rjasanowski, & M. Ziegler. (1999). Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia. 42(6). 661–670. 67 indexed citations
12.
Kaisaki, Pamela J., et al.. (1998). A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene. Diabetic Medicine. 15(10). 816–820. 96 indexed citations
13.
Keilacker, H., I Rjasanowski, W. Besch, & К.-D. Kohnert. (1995). Autoantibodies to Insulin and to Proinsulin in Type 1 Diabetic Patients and in At-Risk Probands Differentiate Only Little between Both Antigens. Hormone and Metabolic Research. 27(2). 90–94. 16 indexed citations
14.
Lühder, Fred, Michael Schlosser, Ludwig Mauch, et al.. (1994). Autoantibodies Against Gad65Rather Than Gad67Precede the Onset of Type 1 Diabetes. Autoimmunity. 19(2). 71–80. 27 indexed citations
15.
Lühder, Fred, Ludwig Mauch, Heinz Haubruck, et al.. (1994). Detection of autoantibodies to the 65-kD isoform of glutamate decarboxylase by radioimmunoassay. European Journal of Endocrinology. 130(6). 575–580. 5 indexed citations
16.
17.
Kuglin, B., et al.. (1990). Antibodies to Proinsulin and Insulin as Predictive Markers of Type 1 Diabetes. Diabetic Medicine. 7(4). 310–314. 12 indexed citations
18.
Jira, Thomas, et al.. (1989). Alterations of purine metabolism in mononuclear cells of individuals at risk of developing type I (insulin-dependent) diabetes mellitus. Clinica Chimica Acta. 183(3). 333–342. 1 indexed citations
19.
20.
Lendeckel, Uwe, et al.. (1988). Restriction-fragment-length-polymorphisms close to the human insulin gene on chromosome 11 and their possible relation to diabetes mellitus in a GDR population.. PubMed. 47(4-5). 311–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antti‐Pekka Laine Breakdown of academic impact, for papers by Birgitta Ehrnström Breakdown of academic impact, for papers by Stina Axelsson Breakdown of academic impact, for papers by Matthias G. von Herrath Breakdown of academic impact, for papers by J. M. McNally Breakdown of academic impact, for papers by Heike E. Naserke Breakdown of academic impact, for papers by DA Heaton Breakdown of academic impact, for papers by I Deschamps Breakdown of academic impact, for papers by S Gough Breakdown of academic impact, for papers by Maki Shintani
Rankless by CCL
2026